Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04920019
What this trial is testing

Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery

Who this might be right for
HepatomaPancreas Cancer
Mahidol University 140
Not applicableStudy completedNCT07272265
What this trial is testing

The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective Study

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sun Yat-sen University 300
Not applicableStudy completedNCT07193316
What this trial is testing

Safety and Efficacy of Atezolizumab-Bevacizumab Versus Tyrosin Kinase Inhibitors in Patients With Liver Cirrhosis

Who this might be right for
Hepatocellular CarcinomaLiver Cirrhosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 38
Not applicableLooking for participantsNCT07760012
What this trial is testing

68Ga-SorB PET/CT Imaging in Patients With Solid Tumors

Who this might be right for
Melanoma (Skin Cancer)Hepatocellular CarcinomaLung Cancer+3 more
Peking University Third Hospital 50
Testing effectiveness (Phase 2)UnknownNCT05617430
What this trial is testing

Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 43
Not applicableLooking for participantsNCT07305428
What this trial is testing

Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study

Who this might be right for
HCC - Hepatocellular CarcinomaUnresectable Hepatocellular Carcinoma
The University of Hong Kong 30
Testing effectiveness (Phase 2)Study completedNCT05003700
What this trial is testing

Hepatic Arterial Infusion Combined With Lenvatinib and Camrelizumab for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University 39
Not applicableLooking for participantsNCT06669377
What this trial is testing

TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 444
Post-approval studies (Phase 4)Not Yet RecruitingNCT07790419
What this trial is testing

A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular Invasion

Who this might be right for
Liver Cancer
Zhai Wenlong 40
Not applicableActive Not RecruitingNCT04367805
What this trial is testing

COVID-19 Infection in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaCOVID-19
Centre Hospitalier Universitaire, Amiens 23
Not applicableLooking for participantsNCT06899854
What this trial is testing

Collection of Blood and Tissue Samples From Patients With Primary Liver Cancer.

Who this might be right for
Hepatocellular Carcinoma (HCC)Cholangiocarcinoma
Fondazione IRCCS Policlinico San Matteo di Pavia 53
Not applicableUnknownNCT05125094
What this trial is testing

Prognostic Performance of Preoperative and Follow by Gadoxetic Enhanced MRI in HCC Patients After TACE

Who this might be right for
Hepatocellular Carcinoma Stage III
Shanghai Zhongshan Hospital 300
Post-approval studies (Phase 4)UnknownNCT05670561
What this trial is testing

Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTranscatheter Arterial ChemoembolizationPain
The Second Affiliated Hospital of Chongqing Medical University 60
Not applicableUnknownNCT04163627
What this trial is testing

Changing Trends in HCC Procedures

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Montpellier 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06313190
What this trial is testing

Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 140
Early research (Phase 1)UnknownNCT04665362
What this trial is testing

IIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCC

Who this might be right for
Advanced/Metastatic Hepatocellular Carcinoma
Liang Peng 10
Testing effectiveness (Phase 2)UnknownNCT04490694
What this trial is testing

TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 54
Not applicableUnknownNCT06328283
What this trial is testing

The Diagnostic Efficacy of Glutamine Synthetaseand BCLAF1in Early Diagosis of Hepatocellular Carcinoma in Cirrhotic Patients

Who this might be right for
Hepatocellular Carcinoma
Sohag University 90
Not applicableActive Not RecruitingNCT05038254
What this trial is testing

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

Who this might be right for
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+42 more
M.D. Anderson Cancer Center 750
Large-scale testing (Phase 3)Ended earlyNCT05171166
What this trial is testing

Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.

Who this might be right for
Hepatocellular Carcinoma
Peking University 18
Next Page